Cited by 26Virus-based gene therapy researchRNA Interference and Gene DeliveryBarrier Structure and Function Studies

Dual Vector Expansion of the Recombinant AAV Packaging Capacity

Duan, Dongsheng, Yue, Yongping, Engelhardt, John F.·2003·Cardiac Cell and Gene Transfer

Abstract

Adeno-associated virus (AAV) as a vector for gene therapy of cardiovascular diseases has received much recent attention (, , , , , ). This enthusiasm is based on the success of numerous proof of principal gene transfer experiments. Stable high-level expression has been achieved following a variety of delivery methods (direct cardiac muscle injection, coronary vascular or carotid artery infection) and in a wide range of animal models from rodents to pigs (, , , , , ). A side-by-side comparison between viral and nonviral vectors in rabbit heart suggests that rAAV is much more efficient than nonviral vectors such as naked or liposome-complexed DNA. At the same time, rAAV also displays the least inflammatory response in comparison with other viral vectors such as adenovirus and herpes simplex virus (). Regulated myocardial transgene expression has also been demonstrated with an AAV vector containing glucocorticoid response elements in rat heart ().

Integrity signals

Registry

Crossref · 10.1385/1-59259-350-x:29

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Authors
Duan, D., Yue, Y., & Engelhardt, J. F.
Affiliations
  • University of Missouri (US)
  • University of Iowa (US)
Venue
Cardiac Cell and Gene Transfer
Publisher
Humana Press
Published
2003-11-15
Volume
219
Pages
29-52
OpenAlex
W2415370792
Cited by
26
References
3
Citations by year
2023: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2012: 1
FWCI
6.66
Type
book chapter
Language
en
Open access
closed
Locations
  • Humana Press eBooks (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (R01HL058340, 2R01 HL 58340)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK 54759, P30DK054759)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
adeno-associated virus, recombinant adeno-associated virus, gene therapy vectors, cardiovascular gene therapy, viral vectors, non-viral vectors, transgene expression regulation
MeSH terms
Dependovirus, Animals, Base Sequence, Cell Line, Genetic Vectors, Humans, Plasmids, Recombination, Genetic, Genetic Therapy, Gene Transfer Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review